This trial tests a drug to relieve Morton's neuroma pain in people aged 18+ who have tried other treatments. Tests, injections, phone calls & follow-ups will be done.
- Morton's Neuroma
2 Primary · 3 Secondary · Reporting Duration: between day 21 and 28
Awards & Highlights
1 Treatment Group
1 of 1
24 Total Participants · 1 Treatment Group
Primary Treatment: Resiniferatoxin · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has Resiniferatoxin received authorization from the FDA yet?
"Our team at Power classified Resiniferatoxin's safety as a 1, due to the Phase 1 trial designation and limited evidence of both efficacy and safety." - Anonymous Online Contributor
Is there currently an open call for participants in this research?
"According to clinicaltrials.gov, this trial has ceased recruiting participants; its last update was on the 26th of January 2023. However, 21 other medical studies are actively enrolling patients at present time." - Anonymous Online Contributor